Comera Life Sciences Holdings, Inc.
CMRA
$0.0001
$0.000.00%
OTC PK
| 09/30/2023 | 06/30/2023 | 03/31/2023 | 12/31/2022 | 09/30/2022 | |
|---|---|---|---|---|---|
| Net Income | -2.15M | -1.41M | -2.48M | -2.96M | -3.08M |
| Total Depreciation and Amortization | 23.00K | 24.80K | 28.30K | 23.80K | 23.80K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 259.60K | 207.80K | 275.40K | 96.10K | 278.80K |
| Change in Net Operating Assets | -43.00K | 185.50K | 271.90K | 995.00K | 384.80K |
| Cash from Operations | -1.91M | -993.50K | -1.91M | -1.85M | -2.39M |
| Capital Expenditure | 0.00 | -5.70K | -88.40K | 0.00 | -25.20K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | 0.00 | -5.70K | -88.40K | 0.00 | -25.20K |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -194.90K | -63.00K | -455.60K | -455.60K | -604.90K |
| Issuance of Common Stock | 3.85M | -- | 2.04M | 80.60K | 750.00K |
| Repurchase of Common Stock | -- | -200.00 | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -453.00K | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | 1.51M | -- |
| Cash from Financing | 3.21M | -63.20K | 1.58M | 1.13M | 145.20K |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 1.29M | -1.06M | -413.60K | -717.10K | -2.27M |